Alan M. Levine - 01 Jun 2021 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role: Director
Signature: /s/ Alan M. Levine
Issuer symbol: AXGN
Transactions as of: 01 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2021, 17:11:58 UTC
Next filing: 03 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXGN	Common Stock	Options Exercise	$0	+6,173	+238%	$0.000000	8,764	01 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXGN	Restricted Stock Units	Options Exercise	$0	-6,173	-100%	$0.000000^*	0	01 Jun 2021	Common Stock	6,173		Direct	F1, F2
transaction	AXGN	Stock Option (right to buy)	Award	$0	+6,030		$0.000000	6,030	01 Jun 2021	Common Stock	6,030	$19.76	Direct	F3
transaction	AXGN	Restricted Stock Units	Award	$0	+3,036		$0.000000	3,036	01 Jun 2021	Common Stock	3,036		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2	This reflects the number of restricted stock units that became vested as of June 1, 2021.
F3	Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2022, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.